Hepatocyte growth factor and interleukin-6 in combination with prostate volume are possible prostate cancer tumor markers in patients with gray-zone PSA levels

Autor:	I. Yoshioka, S. Takahara, Y Namba, Kenji Nishimura, S. Tokugawa, Hidefumi Kishikawa, Naoko Arichi, Y. Ichikawa
Rok vydání:	2007
Předmět:	Adult Male Cancer Research medicine.medical_specialty Urology Sensitivity and Specificity Prostate cancer Reference Values Prostate Biomarkers Tumor medicine Humans Mass Screening Interleukin 6 Aged Aged 80 and over biology Hepatocyte Growth Factor Interleukin-6 business.industry Case-control study Prostatic Neoplasms Interleukin Cancer Organ Size Middle Aged Prostate-Specific Antigen medicine.disease medicine.anatomical_structure Prostate cancer screening Oncology Case-Control Studies biology.protein Hepatocyte growth factor business medicine.drug
Zdroj:	Prostate Cancer and Prostatic Diseases. 11:258-263
ISSN:	1476-5608 1365-7852
DOI:	10.1038/sj.pcan.4501006
Popis:	The aim was to assess whether hepatocyte growth factor (HGF) and interleukin (IL)-6 in combination with prostate volume are able to accurately detect prostate cancer in patients with gray-zone prostate-specific antigen (PSA) levels. A total of 159 patients with PSA levels of
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::093bd7055cac33a4b2554ec5629bddb0 https://doi.org/10.1038/sj.pcan.4501006 Zobrazit plný text záznamu